Tag: biomedical
-
Genome Editing Builds Viral Disease Resistance in Pigs
Veterinary researchers used Crispr-Cas9, an emerging genome editing technique, to produce pigs with cells resistant to a common viral disease affecting commercial herds.
-
Nuclear Cancer Therapy Company Launches, Raises $25M
A new company developing cancer therapies combining nuclear radiation and synthetic antibodies is starting up in Hamilton, Ontario.
-
Handheld Surgical Assist Device in Development
A handheld mechanical device that promises to reduce the cost and ease the work of minimally invasive surgery is being created by a spin-off company from University of Michigan.
-
Biofeedback Device Reduces Panic Attacks in Trial
A medical device that provides people with panic disorder feedback on their abnormal breathing is shown in a clinical trial to reduce panic severity 12 months after treatment.
-
Smart Watch Data Reveal Epilepsy Triggers
Data collected with Apple smart watches show stress and missed sleep tend to trigger more seizures among people with epilepsy than other causes.
-
Patent Issued for Peptides in Diabetes Gene Therapy
A U.S. patent was issued today for synthetic peptides that support gene therapies developed to treat type 2 diabetes and heart failure.
-
Slot Machine Gamblers Get Hooked in Trance-Like State
Findings from a recent study show gamblers who get immersed in playing slot machines are more at risk to develop gambling problems as a result.
-
Stem Cells Launched on Current SpaceX Flight
Yesterday’s SpaceX launch from NASA’s Kennedy Spaceflight Center includes a shipment of adult stem cells to test their growth and proliferation in weightless conditions.
-
Online Pharmacies Seen Fueling Antibiotic Overuse
A study of pharmacies selling drugs online shows many of these sites offer antibiotics to consumers in the U.K. without prescriptions, which would be illegal in retail drug stores.
-
Patent Office Decides for Broad and Editas in Crispr Case
The U.S. Patent and Trademark Office decided that the gene editing processes developed by Broad Institute and licensed to Editas Medicine do not interfere with techniques for genome editing created by University of California at Berkeley.